S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
OTCMKTS:CNBX

CNBX Pharmaceuticals SEC Filings & 10K Form

$8.95
-0.74 (-7.64%)
(As of 05/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.25
$9.70
50-Day Range
$6.76
$10.56
52-Week Range
$0.06
$0.23
Volume
1,402 shs
Average Volume
106,408 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

CNBX Pharmaceuticals (OTCMKTS:CNBX) SEC Filings

DateFilerForm TypeView
04/12/2022
8:57 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/13/2021
8:06 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2021
2:47 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2021
2:51 PM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/06/2021
11:23 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
11:16 PM
CNBX Pharmaceuticals (Filer)
Form EFFECT
05/10/2021
9:40 AM
CNBX Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/28/2021
6:47 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2021
11:42 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/11/2021
11:15 PM
CNBX Pharmaceuticals (Filer)
Form EFFECT
02/23/2021
2:27 PM
CNBX Pharmaceuticals (Filer)
Form S-1/A
01/27/2021
9:08 AM
CNBX Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/21/2020
7:54 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
9:35 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
10:21 AM
CNBX Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/02/2020
2:34 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2020
11:24 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2020
7:03 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2020
7:01 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:03 PM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/29/2019
8:04 AM
CNBX Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/07/2019
4:13 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
3:10 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
9:00 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
12:01 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
12:45 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2019
2:29 PM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2019
11:10 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
11:37 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/27/2019
3:05 PM
CNBX Pharmaceuticals (Filed by)
Wize Pharma, Inc. (Subject)
Form SC 13G
02/13/2019
8:25 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2019
12:21 PM
CNBX Pharmaceuticals (Reporting)
SEEDO CORP. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2019
9:37 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/14/2019
4:00 PM
CNBX Pharmaceuticals (Filer)
Form NT 10-Q
11/29/2018
1:36 PM
CNBX Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/26/2018
7:04 AM
CNBX Pharmaceuticals (Filer)
Form 424B5
09/12/2018
8:09 AM
CNBX Pharmaceuticals (Filer)
Form 424B2
08/21/2018
12:36 PM
CNBX Pharmaceuticals (Filer)
Form 424B2
08/14/2018
11:59 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2018
7:06 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/01/2018
3:31 PM
CNBX Pharmaceuticals (Filer)
Form 424B2
05/02/2018
8:38 AM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2018
11:07 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/30/2018
2:04 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2018
7:02 AM
CNBX Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/19/2017
2:55 PM
CNBX Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2017
8:20 AM
CNBX Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/29/2017
2:37 PM
CNBX Pharmaceuticals (Filer)
Form NT 10-K
This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.